7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Neuropsychiatric disorders are multifactorial disorders with diverse aetiological factors. Identifying treatment targets is challenging because the diseases are resulting from heterogeneous biological, genetic, and environmental factors. Nevertheless, the increasing understanding of G protein-coupled receptor (GPCR) opens a new possibility in drug discovery. Harnessing our knowledge of molecular mechanisms and structural information of GPCRs will be advantageous for developing effective drugs. This review provides an overview of the role of GPCRs in various neurodegenerative and psychiatric diseases. Besides, we highlight the emerging opportunities of novel GPCR targets and address recent progress in GPCR drug development.

          Related collections

          Most cited references808

          • Record: found
          • Abstract: found
          • Article: not found

          The Protein Data Bank.

          The Protein Data Bank (PDB; http://www.rcsb.org/pdb/ ) is the single worldwide archive of structural data of biological macromolecules. This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The role of inflammation in depression: from evolutionary imperative to modern treatment target.

            Crosstalk between inflammatory pathways and neurocircuits in the brain can lead to behavioural responses, such as avoidance and alarm, that are likely to have provided early humans with an evolutionary advantage in their interactions with pathogens and predators. However, in modern times, such interactions between inflammation and the brain appear to drive the development of depression and may contribute to non-responsiveness to current antidepressant therapies. Recent data have elucidated the mechanisms by which the innate and adaptive immune systems interact with neurotransmitters and neurocircuits to influence the risk for depression. Here, we detail our current understanding of these pathways and discuss the therapeutic potential of targeting the immune system to treat depression.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Diagnosis and Treatment of Parkinson Disease: A Review

              Parkinson disease is the most common form of parkinsonism, a group of neurological disorders with Parkinson disease-like movement problems such as rigidity, slowness, and tremor. More than 6 million individuals worldwide have Parkinson disease.
                Bookmark

                Author and article information

                Contributors
                hlli@ecust.edu.cn
                wusong@szu.edu.cn
                yangdu@cuhk.edu.cn
                Journal
                Signal Transduct Target Ther
                Signal Transduct Target Ther
                Signal Transduction and Targeted Therapy
                Nature Publishing Group UK (London )
                2095-9907
                2059-3635
                3 May 2023
                3 May 2023
                2023
                : 8
                : 177
                Affiliations
                [1 ]GRID grid.10784.3a, ISNI 0000 0004 1937 0482, Kobilka Institute of Innovative Drug Discovery, Shenzhen Key Laboratory of Steroid Drug Discovery and Development, School of Medicine, , The Chinese University of Hong Kong, ; 518172 Shenzhen, Guangdong China
                [2 ]GRID grid.12527.33, ISNI 0000 0001 0662 3178, School of Medicine, , Tsinghua University, ; 100084 Beijing, China
                [3 ]GRID grid.263488.3, ISNI 0000 0001 0472 9649, Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, , Shenzhen University, ; 518000 Shenzhen, Guangdong China
                [4 ]GRID grid.28056.39, ISNI 0000 0001 2163 4895, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, , East China University of Science and Technology, ; 200237 Shanghai, China
                [5 ]GRID grid.22069.3f, ISNI 0000 0004 0369 6365, Innovation Center for AI and Drug Discovery, , East China Normal University, ; 200062 Shanghai, China
                [6 ]GRID grid.263488.3, ISNI 0000 0001 0472 9649, Department of Urology, South China Hospital, Health Science Center, , Shenzhen University, ; 518116 Shenzhen, Guangdong China
                Author information
                http://orcid.org/0000-0003-4414-237X
                http://orcid.org/0000-0003-2270-1900
                http://orcid.org/0000-0001-8107-6397
                Article
                1427
                10.1038/s41392-023-01427-2
                10154768
                37137892
                3623b74e-0141-4d96-b06e-54d628466655
                © The Author(s) 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 8 July 2022
                : 17 February 2023
                : 30 March 2023
                Funding
                Funded by: Science, Technology and Innovation Commission of Shenzhen Municipality (Project code JCYJ20200109150019113, GXWD20201231105722002); The Kobilka Institute of Innovative Drug Discovery and Presidential Fellowship at the Chinese University of Hong Kong, Shenzhen, China; National Natural Science Foundation of China (Project code 32271263 to Y. D., Project code 82173690 to S.L., 81825020 and 82150208 to H.L.) The Lingang Laboratory (Project code LG-QS-202206-02 to S.L.)
                Categories
                Review Article
                Custom metadata
                © The Author(s) 2023

                neuroscience,diseases of the nervous system
                neuroscience, diseases of the nervous system

                Comments

                Comment on this article